Delivery Order SPE2DB24D2012-SPE2DB25FBWHP
Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $3,217.50 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S medication. The contract has an ultimate completion date of May 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,674.10 firm-fixed-price delivery order (SPE2DB20D2104|SPE2DB24FT99S) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a prescription medication called MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract has a firm fixed price of $1,647.75 and a completion date of July 10, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $2,062.84 and a period of performance through May 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,542.20, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract has a completion date of February 25, 2025 and is a firm fixed-price delivery order. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,107.65 firm fixed price delivery order contract is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a specialty pharmaceutical product. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The delivery order, valued at $1,569.18, is for the supply of the medication MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
- This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG1TH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.13 delivery order contract is for the supply of the medication MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 5, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on October 30, 2024, is a Firm Fixed Price Delivery Order valued at $1,180.74 with a completion date of October 31, 2024. The contract covers the procurement of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with no set-aside designation. AmerisourceBergen also holds a significant...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,467.90 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corporation's Corporate Office Division to provide MYFEMBREE 40 MG-1 MG-0.5 MG tablets, a pharmaceutical product, with an ultimate completion date of October 9, 2024. This contract is not set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...